Aziyo Biologics (AZYO)
(Real Time Quote from BATS)
$1.15 USD
-0.07 (-5.74%)
Updated Mar 22, 2023 02:11 PM ET
3-Hold of 5 3
F Value C Growth A Momentum C VGM
Price, Consensus and EPS Surprise
AZYO 1.15 -0.07(-5.74%)
Will AZYO be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for AZYO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AZYO
ACER's Stock Down on Failure of Phase II Study, Cash Updates
Catalyst's (CPRX) Q4 Earnings & Sales Top, Boosted by Firdapse
AZYO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Aziyo Biologics, Inc. (AZYO) Upgraded to Buy: Here's What You Should Know
Are Medical Stocks Lagging Bionano Genomics (BNGO) This Year?
Aziyo Biologics, Inc. (AZYO) Reports Q3 Loss, Tops Revenue Estimates
Other News for AZYO
No Record found.